CAR T therapy has yet to be translated for T cell derived leukemias. One study leaves room for hope, as their CAR T product demonstrates early proof-of-concept.
CAR T therapy has yet to be translated for T cell derived leukemias. One study leaves room for hope, as their CAR T product demonstrates early proof-of-concept.